Review



prl tk renilla luciferase control vector  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress prl tk renilla luciferase control vector
    Prl Tk Renilla Luciferase Control Vector, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 141 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/prl tk renilla luciferase control vector/product/MedChemExpress
    Average 95 stars, based on 141 article reviews
    prl tk renilla luciferase control vector - by Bioz Stars, 2026-03
    95/100 stars

    Images



    Similar Products

    96
    ATCC s bombicola atcc 22214
    Comparison of sophorolipid production from S. riodocensis GT-SL1R and S. bombicola <t>ATCC</t> <t>22214</t> in a 5 l fermenter for 7 days. Different letters indicate significant differences, determined by one-way ANOVA and Tukey’s test ( P < 0.05, n = 3).
    S Bombicola Atcc 22214, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s bombicola atcc 22214/product/ATCC
    Average 96 stars, based on 1 article reviews
    s bombicola atcc 22214 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    95
    MedChemExpress prl tk renilla luciferase control vector
    Comparison of sophorolipid production from S. riodocensis GT-SL1R and S. bombicola <t>ATCC</t> <t>22214</t> in a 5 l fermenter for 7 days. Different letters indicate significant differences, determined by one-way ANOVA and Tukey’s test ( P < 0.05, n = 3).
    Prl Tk Renilla Luciferase Control Vector, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/prl tk renilla luciferase control vector/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    prl tk renilla luciferase control vector - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    94
    Thermo Fisher gene exp prl mm00599950 m1
    Comparison of sophorolipid production from S. riodocensis GT-SL1R and S. bombicola <t>ATCC</t> <t>22214</t> in a 5 l fermenter for 7 days. Different letters indicate significant differences, determined by one-way ANOVA and Tukey’s test ( P < 0.05, n = 3).
    Gene Exp Prl Mm00599950 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp prl mm00599950 m1/product/Thermo Fisher
    Average 94 stars, based on 1 article reviews
    gene exp prl mm00599950 m1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    97
    New England Biolabs england biolabs c2987h prl tk renilla luciferase control reporter vector promega e2241 supertop luciferase
    Comparison of sophorolipid production from S. riodocensis GT-SL1R and S. bombicola <t>ATCC</t> <t>22214</t> in a 5 l fermenter for 7 days. Different letters indicate significant differences, determined by one-way ANOVA and Tukey’s test ( P < 0.05, n = 3).
    England Biolabs C2987h Prl Tk Renilla Luciferase Control Reporter Vector Promega E2241 Supertop Luciferase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/england biolabs c2987h prl tk renilla luciferase control reporter vector promega e2241 supertop luciferase/product/New England Biolabs
    Average 97 stars, based on 1 article reviews
    england biolabs c2987h prl tk renilla luciferase control reporter vector promega e2241 supertop luciferase - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    96
    Vector Biolabs constitutive promoter
    Fatty acid treatment induces a proinflammatory phenotype in astrocytes. Relative luminescence produced by firefly luciferase expressed under the control of an NF‐κB‐driven promoter after 24 h of treatment with (A) oleic acid (OA, 50 and 100 μM) and (B) linoleic acid (LA, 50 and 100 μM), in nontransgenic neonatal spinal cord astrocytes cultures. Control cultures were treated with BSA (used as a carrier for FAs). Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a <t>constitutive</t> promoter and expressed as a percentage of vehicle (BSA)‐treated cultures ( n = 3, mean ± SD). (C–F) Representative images depicting immunostaining against NF‐κB‐p65 (red) and GFAP (green) in neonatal spinal cord astrocytes 4 h after treatment with (C) OA (50 μM) or (E) LA (50 μM). Nuclei were counterstained with DAPI (blue). Scale bar: 25 μm. Quantification of NF‐κB‐p65‐positive nuclei in neonatal spinal cord astrocytes 4 h after treatment with (D) OA (50 μM) or (F) LA (50 μM). Data are expressed as NF‐κB‐p65 positive nuclei over the total number of nuclei analyzed, percentage of vehicle (BSA)‐treated cultures ( n = 5, mean ± SD). (G and H) ELISA quantification of CXCL10 (G) and TNFα (H) levels in conditioned media from astrocytes treated with OA (50 μM) and LA (50 μM). Data are expressed as percentage of vehicle (BSA)‐treated control cultures ( n = 2, 5 treatment replicates per experiment, mean ± SD). **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
    Constitutive Promoter, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/constitutive promoter/product/Vector Biolabs
    Average 96 stars, based on 1 article reviews
    constitutive promoter - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress prl h89 group
    Fatty acid treatment induces a proinflammatory phenotype in astrocytes. Relative luminescence produced by firefly luciferase expressed under the control of an NF‐κB‐driven promoter after 24 h of treatment with (A) oleic acid (OA, 50 and 100 μM) and (B) linoleic acid (LA, 50 and 100 μM), in nontransgenic neonatal spinal cord astrocytes cultures. Control cultures were treated with BSA (used as a carrier for FAs). Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a <t>constitutive</t> promoter and expressed as a percentage of vehicle (BSA)‐treated cultures ( n = 3, mean ± SD). (C–F) Representative images depicting immunostaining against NF‐κB‐p65 (red) and GFAP (green) in neonatal spinal cord astrocytes 4 h after treatment with (C) OA (50 μM) or (E) LA (50 μM). Nuclei were counterstained with DAPI (blue). Scale bar: 25 μm. Quantification of NF‐κB‐p65‐positive nuclei in neonatal spinal cord astrocytes 4 h after treatment with (D) OA (50 μM) or (F) LA (50 μM). Data are expressed as NF‐κB‐p65 positive nuclei over the total number of nuclei analyzed, percentage of vehicle (BSA)‐treated cultures ( n = 5, mean ± SD). (G and H) ELISA quantification of CXCL10 (G) and TNFα (H) levels in conditioned media from astrocytes treated with OA (50 μM) and LA (50 μM). Data are expressed as percentage of vehicle (BSA)‐treated control cultures ( n = 2, 5 treatment replicates per experiment, mean ± SD). **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
    Prl H89 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/prl h89 group/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    prl h89 group - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    93
    Cusabio fish prl elisa kit
    Hyperprolactinemia of glis3KD larvae. a Relative mRNA expression of <t>prl</t> CTRL, glis3KD larvae at 120 hpf. qRT-PCR data are normalized to eef1α , and the results are shown as mean ± SD of n = 3 independent replicates. Each data point represents a pool of 20 larvae. Student- t -test was used for statistical analysis between groups: *** P < 0.001. b <t>ELISA</t> of prolactin (ng/ml) in control and glis3KD larvae at 120 hpf. Results (mean ± SD of 3 pools, 50 larvae/pool) were analyzed by Student’s t-test: *** P < 0.001. c , c’ Representative FISH images of prl in CT and KD larvae at 120 hpf. All larvae were acquired by confocal microscopy in ventral view, head to the top. Scale bars in c = 100 µm. d Quantification of total cell volume (µm 3 ) of prl using confocal analysis on the same area (ROI) and number of sections for each embryo. Data are displayed as dot plots with mean ± SD of n = 15 embryos each. Mann–Whitney test was used for statistical analysis, *** P < 0.001. e – f’ IF of prolactin in control and glis3KD larvae in lateral ( e , e’ ) or ventral ( f , f’ ) view. Prl localized in gills (g, asterisks), pectoral fins (pf, arrow), pronephric ducts (pd, arrowheads), forebrain (fb, arrow), and adenohypophysis (ah, arrowhead). Scale bars: e = 300 µm; f = 200 µm. g Mean fluorescence intensity (MFI) of prolactin-positive tissues ( n = 15) using Fiji Software. Mann–Whitney test: ns, not significant; *** P < 0.001
    Fish Prl Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fish prl elisa kit/product/Cusabio
    Average 93 stars, based on 1 article reviews
    fish prl elisa kit - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Comparison of sophorolipid production from S. riodocensis GT-SL1R and S. bombicola ATCC 22214 in a 5 l fermenter for 7 days. Different letters indicate significant differences, determined by one-way ANOVA and Tukey’s test ( P < 0.05, n = 3).

    Journal: FEMS Yeast Research

    Article Title: Optimizing carbon-to-nitrogen ratios for enhanced antimicrobial sophorolipid production in Starmerella riodocensis GT-SL1R

    doi: 10.1093/femsyr/foag007

    Figure Lengend Snippet: Comparison of sophorolipid production from S. riodocensis GT-SL1R and S. bombicola ATCC 22214 in a 5 l fermenter for 7 days. Different letters indicate significant differences, determined by one-way ANOVA and Tukey’s test ( P < 0.05, n = 3).

    Article Snippet: In bioreactor systems, the SL production of S. riodocensis GT-SL1R (55.94 g·l−1) is comparable to the 50.49 g·l−1 from S. bombicola ATCC 22214 under similar batch-fed conditions using glucose and palm oil.

    Techniques: Comparison

    Fatty acid treatment induces a proinflammatory phenotype in astrocytes. Relative luminescence produced by firefly luciferase expressed under the control of an NF‐κB‐driven promoter after 24 h of treatment with (A) oleic acid (OA, 50 and 100 μM) and (B) linoleic acid (LA, 50 and 100 μM), in nontransgenic neonatal spinal cord astrocytes cultures. Control cultures were treated with BSA (used as a carrier for FAs). Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a constitutive promoter and expressed as a percentage of vehicle (BSA)‐treated cultures ( n = 3, mean ± SD). (C–F) Representative images depicting immunostaining against NF‐κB‐p65 (red) and GFAP (green) in neonatal spinal cord astrocytes 4 h after treatment with (C) OA (50 μM) or (E) LA (50 μM). Nuclei were counterstained with DAPI (blue). Scale bar: 25 μm. Quantification of NF‐κB‐p65‐positive nuclei in neonatal spinal cord astrocytes 4 h after treatment with (D) OA (50 μM) or (F) LA (50 μM). Data are expressed as NF‐κB‐p65 positive nuclei over the total number of nuclei analyzed, percentage of vehicle (BSA)‐treated cultures ( n = 5, mean ± SD). (G and H) ELISA quantification of CXCL10 (G) and TNFα (H) levels in conditioned media from astrocytes treated with OA (50 μM) and LA (50 μM). Data are expressed as percentage of vehicle (BSA)‐treated control cultures ( n = 2, 5 treatment replicates per experiment, mean ± SD). **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Journal: Glia

    Article Title: Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes

    doi: 10.1002/glia.70136

    Figure Lengend Snippet: Fatty acid treatment induces a proinflammatory phenotype in astrocytes. Relative luminescence produced by firefly luciferase expressed under the control of an NF‐κB‐driven promoter after 24 h of treatment with (A) oleic acid (OA, 50 and 100 μM) and (B) linoleic acid (LA, 50 and 100 μM), in nontransgenic neonatal spinal cord astrocytes cultures. Control cultures were treated with BSA (used as a carrier for FAs). Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a constitutive promoter and expressed as a percentage of vehicle (BSA)‐treated cultures ( n = 3, mean ± SD). (C–F) Representative images depicting immunostaining against NF‐κB‐p65 (red) and GFAP (green) in neonatal spinal cord astrocytes 4 h after treatment with (C) OA (50 μM) or (E) LA (50 μM). Nuclei were counterstained with DAPI (blue). Scale bar: 25 μm. Quantification of NF‐κB‐p65‐positive nuclei in neonatal spinal cord astrocytes 4 h after treatment with (D) OA (50 μM) or (F) LA (50 μM). Data are expressed as NF‐κB‐p65 positive nuclei over the total number of nuclei analyzed, percentage of vehicle (BSA)‐treated cultures ( n = 5, mean ± SD). (G and H) ELISA quantification of CXCL10 (G) and TNFα (H) levels in conditioned media from astrocytes treated with OA (50 μM) and LA (50 μM). Data are expressed as percentage of vehicle (BSA)‐treated control cultures ( n = 2, 5 treatment replicates per experiment, mean ± SD). **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Article Snippet: Adenovirus expressing a firefly luciferase gene under the control of a synthetic promoter that contains direct repeats of the NF‐κB binding site (Ad‐NFkb‐Luc) or a Renilla luciferase under a constitutive promoter (Ad‐pRL‐Luc) were obtained from Vector Biolabs.

    Techniques: Produced, Luciferase, Control, Activity Assay, Immunostaining, Enzyme-linked Immunosorbent Assay

    Lactate dehydrogenase inhibition reverts the effect of fatty acid treatment in neonatal spinal cord astrocytes. Neonatal spinal cord astrocytes were treated with vehicle (BSA) or fatty acids for 24 h, followed by treatment with vehicle (DMSO) or GSK2837808A (2.5 μM, LDHi) for 24 h. Representative images of LD staining (LipidGreen2) in spinal cord astrocyte cultures treated with (A) oleic acid (OA, 50 μM) in the presence or absence of LDHi (2.5 μM) and (B) linoleic acid (LA, 50 μM) in the presence or absence of LDHi (2.5 μM). Nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. (C) Quantification of LD in spinal cord astrocytes treated as indicated above. LD numbers were normalized by the number of nuclei analyzed ( n = 4, mean ± SD). (D) Relative luminescence produced by firefly luciferase expressed under an NF‐κB‐driven promoter in cultures treated as indicated above. Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a constitutive promoter and expressed as percentage of cultures treated with vehicle (BSA and DMSO) ( n = 3, mean ± SD). (E and F) Motor neuron survival determined 72 h after being plated on top of astrocytes treated as indicated above ( n = 4, mean ± SD). (G) Representative images of LD staining (LipidGreen2) in spinal cord astrocyte cultures treated with OA (50 μM) in the presence or absence of LDHi (2.5 μM), Etomoxir (10 μM, Eto), or both combined (Eto + LDHi). Neonatal spinal cord astrocytes were treated with vehicle (BSA) or fatty acids for 24 h, followed by treatment with vehicle (DMSO) or GSK2837808A (2.5 μM, LDHi) and/or Etomoxir (10 μM) for 24 h. Nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. (H) Quantification of LD in spinal cord astrocytes treated as indicated above. LD numbers were normalized by the number of nuclei analyzed ( n = 3, mean ± SD). **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Journal: Glia

    Article Title: Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes

    doi: 10.1002/glia.70136

    Figure Lengend Snippet: Lactate dehydrogenase inhibition reverts the effect of fatty acid treatment in neonatal spinal cord astrocytes. Neonatal spinal cord astrocytes were treated with vehicle (BSA) or fatty acids for 24 h, followed by treatment with vehicle (DMSO) or GSK2837808A (2.5 μM, LDHi) for 24 h. Representative images of LD staining (LipidGreen2) in spinal cord astrocyte cultures treated with (A) oleic acid (OA, 50 μM) in the presence or absence of LDHi (2.5 μM) and (B) linoleic acid (LA, 50 μM) in the presence or absence of LDHi (2.5 μM). Nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. (C) Quantification of LD in spinal cord astrocytes treated as indicated above. LD numbers were normalized by the number of nuclei analyzed ( n = 4, mean ± SD). (D) Relative luminescence produced by firefly luciferase expressed under an NF‐κB‐driven promoter in cultures treated as indicated above. Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a constitutive promoter and expressed as percentage of cultures treated with vehicle (BSA and DMSO) ( n = 3, mean ± SD). (E and F) Motor neuron survival determined 72 h after being plated on top of astrocytes treated as indicated above ( n = 4, mean ± SD). (G) Representative images of LD staining (LipidGreen2) in spinal cord astrocyte cultures treated with OA (50 μM) in the presence or absence of LDHi (2.5 μM), Etomoxir (10 μM, Eto), or both combined (Eto + LDHi). Neonatal spinal cord astrocytes were treated with vehicle (BSA) or fatty acids for 24 h, followed by treatment with vehicle (DMSO) or GSK2837808A (2.5 μM, LDHi) and/or Etomoxir (10 μM) for 24 h. Nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. (H) Quantification of LD in spinal cord astrocytes treated as indicated above. LD numbers were normalized by the number of nuclei analyzed ( n = 3, mean ± SD). **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Article Snippet: Adenovirus expressing a firefly luciferase gene under the control of a synthetic promoter that contains direct repeats of the NF‐κB binding site (Ad‐NFkb‐Luc) or a Renilla luciferase under a constitutive promoter (Ad‐pRL‐Luc) were obtained from Vector Biolabs.

    Techniques: Inhibition, Staining, Produced, Luciferase, Activity Assay

    Lactate dehydrogenase gene ablation reverts the effect of fatty acid treatment in neonatal spinal cord astrocytes. (A) Primary confluent spinal cord astrocyte cultures obtained from neonatal Ldha flox/flox mice were transduced with an adenovirus expressing Cre recombinase (CRE) or an empty ORF (NULL). Seventy‐two hours later lactate dehydrogenase A (LDHA) expression was analyzed by Western blot. (B) LDHA expression was quantified, normalized by actin levels, and expressed as a percentage of NULL‐treated cultures ( n = 3, mean ± SD). (C) Ldha flox/flox spinal cord astrocyte cultures treated as above were subsequently exposed to oleic acid (OA, 50 μM) for 24 h. Representative images of LD staining (LipidGreen2). Nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. (D) Quantification of LD in spinal cord astrocytes treated as indicated in (C). LD numbers were normalized by the number of nuclei analyzed ( n = 3, mean ± SD). (E) Relative luminescence produced by firefly luciferase expressed under an NF‐κB‐driven promoter in cultures treated as indicated in (C). Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a constitutive promoter and expressed as percentage of control cultures (NULL/BSA) ( n = 4, mean ± SD). (F) Motor neuron survival determined 72 h after being plated on top of Ldha flox/flox spinal astrocytes treated as indicated in (C) ( n = 4, mean ± SD). **** p < 0.0001, ** p < 0.01, *p < 0.05.

    Journal: Glia

    Article Title: Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes

    doi: 10.1002/glia.70136

    Figure Lengend Snippet: Lactate dehydrogenase gene ablation reverts the effect of fatty acid treatment in neonatal spinal cord astrocytes. (A) Primary confluent spinal cord astrocyte cultures obtained from neonatal Ldha flox/flox mice were transduced with an adenovirus expressing Cre recombinase (CRE) or an empty ORF (NULL). Seventy‐two hours later lactate dehydrogenase A (LDHA) expression was analyzed by Western blot. (B) LDHA expression was quantified, normalized by actin levels, and expressed as a percentage of NULL‐treated cultures ( n = 3, mean ± SD). (C) Ldha flox/flox spinal cord astrocyte cultures treated as above were subsequently exposed to oleic acid (OA, 50 μM) for 24 h. Representative images of LD staining (LipidGreen2). Nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. (D) Quantification of LD in spinal cord astrocytes treated as indicated in (C). LD numbers were normalized by the number of nuclei analyzed ( n = 3, mean ± SD). (E) Relative luminescence produced by firefly luciferase expressed under an NF‐κB‐driven promoter in cultures treated as indicated in (C). Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a constitutive promoter and expressed as percentage of control cultures (NULL/BSA) ( n = 4, mean ± SD). (F) Motor neuron survival determined 72 h after being plated on top of Ldha flox/flox spinal astrocytes treated as indicated in (C) ( n = 4, mean ± SD). **** p < 0.0001, ** p < 0.01, *p < 0.05.

    Article Snippet: Adenovirus expressing a firefly luciferase gene under the control of a synthetic promoter that contains direct repeats of the NF‐κB binding site (Ad‐NFkb‐Luc) or a Renilla luciferase under a constitutive promoter (Ad‐pRL‐Luc) were obtained from Vector Biolabs.

    Techniques: Transduction, Expressing, Western Blot, Staining, Produced, Luciferase, Activity Assay, Control

    Lactate dehydrogenase inhibition ameliorates the neurotoxic phenotype of spinal cord astrocytes isolated from symptomatic hSOD1 G93A mice. (A) Representative LD staining (LipidGreen2) in spinal cord astrocyte cultures from symptomatic hSOD1 G93A (G93A) mice treated with GSK2837808A (2.5 μM, LDHi) or vehicle (DMSO) for 24 h. Nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. (B) Quantification of LD normalized by the number of nuclei analyzed ( n = 3, mean ± SD). (C) Relative luminescence produced by firefly luciferase expressed under an NF‐κB‐driven promoter in cultures treated as indicated above. Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a constitutive promoter and expressed as percentage of cultures treated with vehicle (DMSO) ( n = 3, mean ± SD). (D) Motor neuron survival in co‐cultures with spinal cord astrocytes from symptomatic hSOD1 G93A mice treated as in (A) ( n = 4, mean ± SD). * p < 0.05.

    Journal: Glia

    Article Title: Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes

    doi: 10.1002/glia.70136

    Figure Lengend Snippet: Lactate dehydrogenase inhibition ameliorates the neurotoxic phenotype of spinal cord astrocytes isolated from symptomatic hSOD1 G93A mice. (A) Representative LD staining (LipidGreen2) in spinal cord astrocyte cultures from symptomatic hSOD1 G93A (G93A) mice treated with GSK2837808A (2.5 μM, LDHi) or vehicle (DMSO) for 24 h. Nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. (B) Quantification of LD normalized by the number of nuclei analyzed ( n = 3, mean ± SD). (C) Relative luminescence produced by firefly luciferase expressed under an NF‐κB‐driven promoter in cultures treated as indicated above. Relative firefly luciferase luminescence was corrected by the amount of Renilla luciferase activity controlled by a constitutive promoter and expressed as percentage of cultures treated with vehicle (DMSO) ( n = 3, mean ± SD). (D) Motor neuron survival in co‐cultures with spinal cord astrocytes from symptomatic hSOD1 G93A mice treated as in (A) ( n = 4, mean ± SD). * p < 0.05.

    Article Snippet: Adenovirus expressing a firefly luciferase gene under the control of a synthetic promoter that contains direct repeats of the NF‐κB binding site (Ad‐NFkb‐Luc) or a Renilla luciferase under a constitutive promoter (Ad‐pRL‐Luc) were obtained from Vector Biolabs.

    Techniques: Inhibition, Isolation, Staining, Produced, Luciferase, Activity Assay

    Hyperprolactinemia of glis3KD larvae. a Relative mRNA expression of prl CTRL, glis3KD larvae at 120 hpf. qRT-PCR data are normalized to eef1α , and the results are shown as mean ± SD of n = 3 independent replicates. Each data point represents a pool of 20 larvae. Student- t -test was used for statistical analysis between groups: *** P < 0.001. b ELISA of prolactin (ng/ml) in control and glis3KD larvae at 120 hpf. Results (mean ± SD of 3 pools, 50 larvae/pool) were analyzed by Student’s t-test: *** P < 0.001. c , c’ Representative FISH images of prl in CT and KD larvae at 120 hpf. All larvae were acquired by confocal microscopy in ventral view, head to the top. Scale bars in c = 100 µm. d Quantification of total cell volume (µm 3 ) of prl using confocal analysis on the same area (ROI) and number of sections for each embryo. Data are displayed as dot plots with mean ± SD of n = 15 embryos each. Mann–Whitney test was used for statistical analysis, *** P < 0.001. e – f’ IF of prolactin in control and glis3KD larvae in lateral ( e , e’ ) or ventral ( f , f’ ) view. Prl localized in gills (g, asterisks), pectoral fins (pf, arrow), pronephric ducts (pd, arrowheads), forebrain (fb, arrow), and adenohypophysis (ah, arrowhead). Scale bars: e = 300 µm; f = 200 µm. g Mean fluorescence intensity (MFI) of prolactin-positive tissues ( n = 15) using Fiji Software. Mann–Whitney test: ns, not significant; *** P < 0.001

    Journal: Journal of Molecular Medicine (Berlin, Germany)

    Article Title: Glis3 as a critical regulator of Pit1-lineages and renal functions

    doi: 10.1007/s00109-025-02611-3

    Figure Lengend Snippet: Hyperprolactinemia of glis3KD larvae. a Relative mRNA expression of prl CTRL, glis3KD larvae at 120 hpf. qRT-PCR data are normalized to eef1α , and the results are shown as mean ± SD of n = 3 independent replicates. Each data point represents a pool of 20 larvae. Student- t -test was used for statistical analysis between groups: *** P < 0.001. b ELISA of prolactin (ng/ml) in control and glis3KD larvae at 120 hpf. Results (mean ± SD of 3 pools, 50 larvae/pool) were analyzed by Student’s t-test: *** P < 0.001. c , c’ Representative FISH images of prl in CT and KD larvae at 120 hpf. All larvae were acquired by confocal microscopy in ventral view, head to the top. Scale bars in c = 100 µm. d Quantification of total cell volume (µm 3 ) of prl using confocal analysis on the same area (ROI) and number of sections for each embryo. Data are displayed as dot plots with mean ± SD of n = 15 embryos each. Mann–Whitney test was used for statistical analysis, *** P < 0.001. e – f’ IF of prolactin in control and glis3KD larvae in lateral ( e , e’ ) or ventral ( f , f’ ) view. Prl localized in gills (g, asterisks), pectoral fins (pf, arrow), pronephric ducts (pd, arrowheads), forebrain (fb, arrow), and adenohypophysis (ah, arrowhead). Scale bars: e = 300 µm; f = 200 µm. g Mean fluorescence intensity (MFI) of prolactin-positive tissues ( n = 15) using Fiji Software. Mann–Whitney test: ns, not significant; *** P < 0.001

    Article Snippet: Prolactin levels (ng/ml) were measured using a Fish PRL ELISA Kit (CusaBio, CSB-E12695Fh).

    Techniques: Expressing, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Control, Confocal Microscopy, MANN-WHITNEY, Fluorescence, Software